Literature DB >> 32376678

The Effects of Intensive Blood Pressure Lowering on Markers of Mineral Metabolism in Persons with CKD in SPRINT.

Charles Ginsberg1,2, Ronit Katz3, Michel B Chonchol4, Alexander L Bullen5,2, Kalani L Raphael6, William R Zhang7,8, Walter T Ambrosius9, Jeffrey T Bates10, Javier A Neyra11, Anthony A Killeen12, Henry Punzi13, Michael G Shlipak7,14, Joachim H Ix5,2.   

Abstract

Entities:  

Keywords:  Antihypertensive Agents; Biomarkers; Chronic; Minerals; Renal Insufficiency; blood pressure; calcium; chronic kidney disease; hypertension; mineral metabolism

Mesh：

Substances：

Year:  2020        PMID： 32376678      PMCID： PMC7274286          DOI： 10.2215/CJN.01400220

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  6 in total

1.  Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.

Authors:  Tamara Isakova; Xuan Cai; Jungwha Lee; Dawei Xie; Xue Wang; Rupal Mehta; Norrina B Allen; Julia J Scialla; Michael J Pencina; Amanda H Anderson; John Talierco; Jing Chen; Michael J Fischer; Susan P Steigerwalt; Mary B Leonard; Chi-Yuan Hsu; Ian H de Boer; John W Kusek; Harold I Feldman; Myles Wolf
Journal:  J Am Soc Nephrol       Date:  2017-11-22       Impact factor: 10.121

2.  PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Authors:  Charles Ginsberg; Timothy E Craven; Michel B Chonchol; Alfred K Cheung; Mark J Sarnak; Walter T Ambrosius; Anthony A Killeen; Kalani L Raphael; Udayan Y Bhatt; Jing Chen; Glenn M Chertow; Barry I Freedman; Suzanne Oparil; Vasilios Papademetriou; Barry M Wall; Clinton B Wright; Joachim H Ix; Michael G Shlipak
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-13       Impact factor: 8.237

3.  Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

Authors:  Orlando M Gutiérrez; Michael Mannstadt; Tamara Isakova; Jose Alejandro Rauh-Hain; Hector Tamez; Anand Shah; Kelsey Smith; Hang Lee; Ravi Thadhani; Harald Jüppner; Myles Wolf
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

4.  Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.

Authors:  Rakesh Malhotra; Timothy Craven; Walter T Ambrosius; Anthony A Killeen; William E Haley; Alfred K Cheung; Michel Chonchol; Mark Sarnak; Chirag R Parikh; Michael G Shlipak; Joachim H Ix
Journal:  Am J Kidney Dis       Date:  2018-10-02       Impact factor: 8.860

5.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

6.  Effects of Intensive BP Control in CKD.

Authors:  Alfred K Cheung; Mahboob Rahman; David M Reboussin; Timothy E Craven; Tom Greene; Paul L Kimmel; William C Cushman; Amret T Hawfield; Karen C Johnson; Cora E Lewis; Suzanne Oparil; Michael V Rocco; Kaycee M Sink; Paul K Whelton; Jackson T Wright; Jan Basile; Srinivasan Beddhu; Udayan Bhatt; Tara I Chang; Glenn M Chertow; Michel Chonchol; Barry I Freedman; William Haley; Joachim H Ix; Lois A Katz; Anthony A Killeen; Vasilios Papademetriou; Ana C Ricardo; Karen Servilla; Barry Wall; Dawn Wolfgram; Jerry Yee
Journal:  J Am Soc Nephrol       Date:  2017-06-22       Impact factor: 10.121
  6 in total
  1 in total

Review 1.  Fibroblast growth factor 23-Klotho and hypertension: experimental and clinical mechanisms.

Authors:  Michael Freundlich; Gerardo Gamba; Bernardo Rodriguez-Iturbe
Journal:  Pediatr Nephrol       Date:  2020-11-23       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.